Problems and solutions for testing hemostasis assays while patients are on anticoagulants

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Anticoagulant drugs affect directly or indirectly several coagulation parameters. This article is aimed at reviewing the problems encountered while testing patients on treatment and presents potential solutions. In general, it is recommended to postpone the performance of laboratory investigation upon discontinuation of the drug, preferably 2 days or more depending on the drug's half-life. If this strategy is unfeasible and patients remain on treatment, results of testing will likely be affected and result interpretation then requires great caution and knowledge of the peculiar and differential mechanism of action of the relevant anticoagulant drug being used.

Original languageEnglish
Pages (from-to)586-592
Number of pages7
JournalSeminars in Thrombosis and Hemostasis
Volume38
Issue number6
DOIs
Publication statusPublished - 2012

Fingerprint

Hemostasis
Anticoagulants
Pharmaceutical Preparations
Half-Life
Therapeutics

Keywords

  • anticoagulant drugs
  • direct inhibitors
  • hemostasis assays
  • heparins
  • laboratory tests
  • vitamin K antagonists

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Problems and solutions for testing hemostasis assays while patients are on anticoagulants. / Tripodi, Armando.

In: Seminars in Thrombosis and Hemostasis, Vol. 38, No. 6, 2012, p. 586-592.

Research output: Contribution to journalArticle

@article{b0c60bd76e56450694590085919be6a2,
title = "Problems and solutions for testing hemostasis assays while patients are on anticoagulants",
abstract = "Anticoagulant drugs affect directly or indirectly several coagulation parameters. This article is aimed at reviewing the problems encountered while testing patients on treatment and presents potential solutions. In general, it is recommended to postpone the performance of laboratory investigation upon discontinuation of the drug, preferably 2 days or more depending on the drug's half-life. If this strategy is unfeasible and patients remain on treatment, results of testing will likely be affected and result interpretation then requires great caution and knowledge of the peculiar and differential mechanism of action of the relevant anticoagulant drug being used.",
keywords = "anticoagulant drugs, direct inhibitors, hemostasis assays, heparins, laboratory tests, vitamin K antagonists",
author = "Armando Tripodi",
year = "2012",
doi = "10.1055/s-0032-1319769",
language = "English",
volume = "38",
pages = "586--592",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "6",

}

TY - JOUR

T1 - Problems and solutions for testing hemostasis assays while patients are on anticoagulants

AU - Tripodi, Armando

PY - 2012

Y1 - 2012

N2 - Anticoagulant drugs affect directly or indirectly several coagulation parameters. This article is aimed at reviewing the problems encountered while testing patients on treatment and presents potential solutions. In general, it is recommended to postpone the performance of laboratory investigation upon discontinuation of the drug, preferably 2 days or more depending on the drug's half-life. If this strategy is unfeasible and patients remain on treatment, results of testing will likely be affected and result interpretation then requires great caution and knowledge of the peculiar and differential mechanism of action of the relevant anticoagulant drug being used.

AB - Anticoagulant drugs affect directly or indirectly several coagulation parameters. This article is aimed at reviewing the problems encountered while testing patients on treatment and presents potential solutions. In general, it is recommended to postpone the performance of laboratory investigation upon discontinuation of the drug, preferably 2 days or more depending on the drug's half-life. If this strategy is unfeasible and patients remain on treatment, results of testing will likely be affected and result interpretation then requires great caution and knowledge of the peculiar and differential mechanism of action of the relevant anticoagulant drug being used.

KW - anticoagulant drugs

KW - direct inhibitors

KW - hemostasis assays

KW - heparins

KW - laboratory tests

KW - vitamin K antagonists

UR - http://www.scopus.com/inward/record.url?scp=84866089734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866089734&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1319769

DO - 10.1055/s-0032-1319769

M3 - Article

C2 - 22718257

AN - SCOPUS:84866089734

VL - 38

SP - 586

EP - 592

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 6

ER -